Page 3 – Quest National Services

ENT CPT® Codes for 2026 + Modifiers

ENT billing in 2026 reflects some of the most significant coding updates seen in years, particularly across audiology services, sleep apnea procedures, remote monitoring, and minimally invasive thyroid treatments. As payers tighten medical necessity requirements and adjust telehealth policies, accurate CPT® reporting and modifier usage are more important than ever. If your team is still relying on outdated hearing aid codes or inconsistent documentation for remote services, 2026 will expose those gaps quickly.

Below is a detailed breakdown of the ENT CPT® codes, deletions, and documentation risks practices must understand to protect reimbursement this year.

ENT denials in 2026 are driven by documentation gaps—not random payer behavior.

We repeatedly see rejected claims tied to deleted hearing aid codes, unsupported remote monitoring time, and incomplete anatomical documentation for new sleep procedures. These are predictable issues—and preventable.

Guarantee: We’ll identify the exact coding and documentation breakdowns impacting your ENT claims and deliver a clear correction plan.

Get My ENT Denial Snapshot

ENT CPT® Code Highlights for 2026

Remote monitoring and remote therapeutic management remain major reimbursement drivers in 2026. New thresholds and shorter monitoring windows create opportunities—but also compliance risk when documentation fails to support time and medical necessity.

CPT® Code	Description
99445	Remote monitoring device supply and transmission (2–15 days within 30-day period)
99470	Remote monitoring treatment management, first 10 minutes
98975	Initial setup and patient education for remote therapeutic/physiologic monitoring
98980	Remote monitoring treatment management, first 20 minutes per calendar month

Documentation Risk: Time thresholds must be clearly supported. Payers increasingly request proof of device activation dates, transmission logs, and staff time documentation.

Remote monitoring claims often deny due to unsupported time documentation.

We commonly see rejected claims for 99445 and 99470 when monitoring duration or staff time isn’t explicitly documented. Payers expect timestamps, device confirmation, and active management notes.

Guarantee: We’ll pinpoint where your remote monitoring documentation fails—and show you how to make it audit-proof.

Fix My Remote Monitoring Denials

Major Audiology Coding Changes for 2026

The largest ENT billing shift for 2026 is the complete retirement of legacy hearing aid codes 92590–92595 and the introduction of a detailed, time-based hearing device service family.

Deleted for 2026: CPT® codes 92590–92595 are no longer valid for billing.

New CPT® Code Range	Description
92628–92629	Hearing aid candidacy evaluation (time-based)
92631–92632	Hearing aid selection services
92634–92635	Hearing aid fitting and orientation (first 60 minutes + add-on time)
92636–92637	Post-fitting follow-up and adjustment services
92638–92641	Hearing aid verification services (behavioral/probe measures)

These codes shift reimbursement from bundled service models to transparent, time-based reporting. That increases revenue potential—but only if provider time and complexity are clearly documented.

Billing deleted hearing aid codes will trigger immediate rejections.

We’re seeing practices accidentally submit 92590–92595 in early 2026, leading to invalid-code denials. Even when using new codes, insufficient time documentation leads to downcoding or payer audits.

Guarantee: We’ll identify your hearing aid billing risks and implement safeguards to prevent repeat denials.

Audit My Audiology Claims

New ENT Sleep Apnea Treatment Codes for 2026

ENT practices managing sleep-disordered breathing should pay close attention to new Category I CPT® codes for cryolysis of the posterior nasal nerve. These services now differentiate anatomical site, creating documentation precision requirements.

Cryolysis of the soft palate
Cryolysis of the base of tongue
Cryolysis of the lingual tonsils

Claims must clearly identify the exact anatomical structure treated. Generic documentation like “posterior nasal nerve cryotherapy” may not be sufficient for payer review.

High-value sleep procedure claims deny when anatomical documentation is vague.

Payers now differentiate based on treatment location. If your operative note doesn’t clearly state soft palate vs. base of tongue vs. lingual tonsils, reimbursement can stall.

Guarantee: We’ll review your operative documentation patterns and identify exposure points before audits occur.

Protect My Sleep Procedure Revenue

ENT Surgical and Diagnostic Codes to Know in 2026

CPT® Code	Description
31233	Diagnostic nasal/sinus endoscopy with maxillary sinusoscopy
31235	Diagnostic nasal/sinus endoscopy with sphenoid sinusoscopy
31292–31298	Surgical nasal/sinus endoscopy procedures
60660	Thyroid radiofrequency ablation, single lobe
60661	Thyroid RFA, additional lobe
74210–74230	Radiologic swallowing studies
92557–92587	Audiologic diagnostic testing
92626–92627	Postoperative evaluation of auditory implants
94728	Oscillometry airway resistance testing
99243	Office/outpatient consultation

Note: CPT® 60660 and 60661 remain key minimally invasive thyroid RFA services entering 2026, with payer policies continuing to evolve.

ENT CPT® Modifiers That Prevent Denials

Modifier	Common Use in ENT
93	Audio-only telemedicine (payer permitted)
95	Synchronous telemedicine (audio-video)
-25	Separate E/M service on same day as procedure
-59	Distinct procedural service

Improper modifier use—especially -25 and -59—remains one of the top ENT denial drivers nationally.

Summary of Key 2026 ENT Coding Changes

New 2026 Code	Description	Replacing (Deleted)
92628–92629	Hearing aid candidacy evaluation	92590–92591
92634–92635	Hearing aid fitting/orientation	92594–92595
99445	Remote monitoring supply	New service structure
99470	RTM management (10 min)	Lower time threshold

Final Thoughts

ENT CPT® coding in 2026 demands greater documentation precision, particularly for audiology services, remote monitoring, thyroid RFA, and sleep-related procedures. Practices that proactively update templates and billing workflows will avoid preventable denials and accelerate reimbursement.

If your ENT claims are slowing cash flow, the problem is fixable.

Whether you’re facing remote monitoring denials, hearing aid transition issues, or modifier-related rejections, we’ve seen these patterns repeatedly—and corrected them.

Guarantee: We’ll identify your top denial drivers and give you a structured fix plan that protects reimbursement.

Get My ENT Denial Snapshot

Trademark notice: CPT is a registered trademark of the American Medical Association.

Gastroenterology CPT® Codes for 2026 + Modifiers

Gastroenterology billing in 2026 reflects some of the most meaningful updates the specialty has seen in years. The AMA and GI Tri-Society (AGA, ACG, ASGE) have modernized anorectal testing, formalized bariatric endoscopy with a permanent CPT® code, expanded remote monitoring flexibility, and tightened compliance rules for screening colonoscopies.

Below is your updated guide to Gastroenterology CPT® codes and modifiers for 2026, including key revenue and compliance alerts your billing team needs to know.

GI denials usually aren’t “random”—they’re tied to predictable screening, documentation, and modifier mistakes.

We see the same friction points repeatedly in gastroenterology: screening vs. diagnostic mismatches on colonoscopy claims, incomplete documentation supporting medical necessity for anorectal testing, and inconsistent modifier use when multiple services occur in a single session. In 2026, those small gaps trigger big payer pushback.

Guarantee: We’ll identify the top denial causes in your GI claims and give you a clear plan to stop them.

Get My GI Denial Snapshot

Evaluation and Management Codes Common in Gastroenterology

Many GI revenue-cycle issues start with E/M documentation—especially when an office visit turns into same-day testing, a procedure is scheduled based on symptoms, or a “screening” colonoscopy becomes diagnostic. If E/M is billed separately on the same date as another service, payers expect documentation that clearly supports a distinct, separately identifiable service (and appropriate modifier use when required).

CPT® Code	Description
99202–99205	New patient office/outpatient visits (levels 2–5)
99212–99215	Established patient office/outpatient visits (levels 2–5)
99221–99223	Initial hospital inpatient or observation care
99231–99233	Subsequent hospital inpatient or observation care

Document the “Why Today”

Tip: When an office visit and a procedure or test occur on the same date, clearly separate the assessment/plan (medical decision-making) from the procedure note to support modifier use and reduce “bundled” denials.

Getting paid for GI E/M is hard when payers think it’s “bundled” into the procedure.

We see denials when 99213–99215 (or 99202–99205) are billed on the same day as testing or a procedure and the note doesn’t clearly justify a separate, significant service—especially when modifier -25 is used. We know what payers look for and where GI documentation typically fails.

Guarantee: We’ll pinpoint exactly why your E/M claims are denied and show you what to change so the next batch pays.

Analyze My E/M + Procedure Denials

Contact us to get a Denial Snapshot highlighting E/M + procedure denial drivers and the fixes that restore reimbursement.

Major 2026 CPT® Code Additions & Overhauls

Gastroenterology saw several “structure-level” changes in 2026 that affect coding, documentation expectations, and how claims are reviewed. The most common issues we see happen when teams keep older workflow assumptions (like legacy anorectal testing reporting or older HCPCS crosswalks) even after codes and descriptors have changed.

Endobariatrics: Endoscopic Sleeve Gastroplasty (ESG)

CPT® Code	Description	2026 Impact
43889	Gastric restrictive procedure, transoral, endoscopic sleeve gastroplasty (ESG)	Replaces HCPCS C9784; includes APC when performed

Global Period: 43889 carries a 90-day global period. All routine follow-up care is bundled into the surgical payment. Practices must ensure post-op visits are not separately billed unless unrelated.

Practical billing note: When claims deny, it’s often not the code—it’s the supporting documentation and how the episode is framed. Align your op note elements (indication, technique, device/suture method as applicable, findings, and complications) with payer expectations so the claim is defensible on first pass.

Anorectal Physiology Testing Modernization

The legacy codes 91120 and 91122 have been deleted. They are replaced with more comprehensive and bundled testing descriptors.

CPT® Code	Description
91124	Rectal sensation, tone, and compliance testing (e.g., barostat)
91125	Anorectal manometry including anal sphincter pressures, reflexes, rectal sensation, and balloon expulsion (when performed)

These updated codes better reflect comprehensive pelvic floor disorder testing and reduce the need for multiple line-item reporting.

Common denial trigger: When payers don’t see a clear medical-necessity story (symptoms, failed conservative management when applicable, and test intent tied to clinical decision-making), they’re more likely to deny—even if the code is correct. Make sure the note answers “what are we evaluating, and what will we do with the result?”

Liver Tumor Ablation “Graduation”

CPT® Code	Description	Update
47384	Percutaneous irreversible electroporation (IRE) of liver tumor(s)	Graduated from Category III (0600T) to permanent Category I

This permanent Category I status significantly improves reimbursement stability. Imaging guidance is included.

When GI codes “change,” payers don’t just update software—they tighten edits and documentation expectations.

We see preventable denials when teams don’t fully operationalize 2026 changes—like treating anorectal testing as legacy line-item reporting or mishandling newer bariatric endoscopy episodes. The result is delayed cash flow, repeated requests for records, and rework that eats staff time.

Guarantee: We’ll identify the exact code-transition and documentation risks in your GI workflow and show you how to fix them.

Check My 2026 GI Code Risk

Remote Monitoring for Chronic GI Conditions

For patients with IBD, cirrhosis, obesity, or chronic liver disease, remote monitoring continues to expand in 2026. The opportunity is real—but so is payer scrutiny. Claims typically pay when you can demonstrate the required device/supply elements, an automatic transmission workflow (when required), and clear documentation of time spent reviewing data and managing treatment.

Code	Description
99445	Remote monitoring supply and transmission (2–15 days)
99454	Remote monitoring supply (16+ days; automatic transmission required)
99470	Remote monitoring treatment management, first 10 minutes

Lower Management Threshold: 99470 lowers the prior 20-minute threshold, allowing reimbursement for the first 10 minutes of data review.

Compliance Update: For 2026, 99454 requires automatic device transmission. Manual patient logs, emailed food diaries, or text-reported symptom trackers no longer qualify.

Operational reminder: Remote monitoring revenue often fails due to workflow, not coding. If the clinical team collects data but the billing team can’t prove transmission requirements or time thresholds, payers treat the claim as non-compliant—even when the patient benefited clinically.

Remote monitoring in GI is a payer “favorite” to deny when the workflow isn’t airtight.

We commonly see denials tied to missing documentation of device transmission requirements, unclear time tracking, or notes that don’t connect data review to treatment decisions. In 2026, the automatic transmission requirement for 99454 is an easy way for payers to reject claims.

Guarantee: We’ll identify the top compliance gaps in your remote monitoring claims and provide fixes that reduce denials.

Review My Remote Monitoring Claims

Contact us to receive a Denial Snapshot that pinpoints why your remote monitoring claims aren’t getting paid—and how to fix it.

Core Gastroenterology Procedure Codes

Foundational endoscopy services remain unchanged structurally but are subject to a -2.5% efficiency adjustment to work RVUs in 2026. That makes clean claims more important—because when reimbursement tightens, denials and delays hurt more.

Upper GI Endoscopy (EGD)

CPT® Code	Description
43235	Diagnostic EGD
43239	EGD with biopsy
43249	EGD with balloon dilation (<30 mm)

Colonoscopy

CPT® Code	Description
45378	Diagnostic or screening colonoscopy
45380	Colonoscopy with biopsy
45385	Colonoscopy with snare polypectomy
45384	Colonoscopy with hot biopsy forceps

Screening Conversion Alert: If a colonoscopy begins as screening (Z12.11) but a polyp is removed, Medicare requires Modifier -PT. Commercial payers may require Modifier -33 for preventive designation.

Documentation tip: Make sure the procedure documentation supports the “why” and the “what changed.” Screening-to-diagnostic claims are frequently denied when the diagnosis, modifier, and documentation don’t match the clinical story.

Colonoscopy denials often come down to screening logic, modifier selection, and diagnosis support—not the procedure itself.

We see payers deny or reprocess claims when screening intent isn’t clearly supported, when -PT or -33 is missing/misapplied, or when diagnosis selection doesn’t align with the claim narrative. In 2026, payers are using more automated edits to flag inconsistencies.

Guarantee: We’ll identify exactly why your endoscopy claims aren’t paying and give you a fix plan you can implement immediately.

Fix My Endoscopy Denials

Gastroenterology Diagnostic Testing CPT® Codes To Know

Diagnostic testing is a frequent denial trigger in GI—especially when medical necessity, symptom severity, and prior conservative management are not clearly documented. Even when payers approve the test, they may deny the claim if the note doesn’t support why the test was appropriate on that date.

CPT® Code	Description
91124	Rectal sensation, tone, and compliance testing (e.g., barostat)
91125	Anorectal manometry including anal sphincter pressures, reflexes, rectal sensation, and balloon expulsion (when performed)

Medical-necessity reminder: Clearly document symptoms (duration, severity, functional impact), prior therapies, and how results will impact the plan of care. This is the “defense” payers look for when deciding whether to reimburse.

Diagnostic testing denials happen when payers don’t see medical necessity—so they don’t pay.

For services like anorectal physiology testing, we commonly see denials tied to missing indications, incomplete symptom documentation, or lack of conservative management detail in the note. We know the patterns payers use to deny these tests and what documentation makes claims defensible.

Guarantee: We’ll identify the top medical-necessity denial triggers in your GI testing claims and show you how to correct them.

Review My Testing Denials

Common Surgical Procedures and 2026 New Standards

GI teams are also navigating shifting reimbursement and payer edits for higher-acuity services. The 2026 environment rewards tight documentation—because the more expensive the claim, the more likely it is to be reviewed. Make sure your operative/procedure documentation is consistent, complete, and clearly supports medical necessity and technique.

CPT® Code	Description	2026 Focus
43889	Gastric restrictive procedure, transoral, endoscopic sleeve gastroplasty (ESG)	90-day global; ensure post-op billing compliance
47384	Percutaneous irreversible electroporation (IRE) of liver tumor(s)	Now Category I; imaging guidance included

High-dollar GI claims hurt the most when they deny—because every day unpaid is real revenue at risk.

We see denials and payer requests spike when documentation doesn’t clearly support newer or higher-acuity services. Even when the CPT® code is correct, incomplete medical-necessity support or missing operative detail can stall reimbursement.

Guarantee: We’ll uncover what’s blocking reimbursement on your high-dollar claims and give you a step-by-step fix plan.

Check My High-Dollar Claims

A Quick 2026 “Watch List” for GI Teams

The highest-risk denials and delays in 2026 tend to come from workflow “misses,” not complex coding theory. Here are the items most likely to trigger rejections, recoupments, or repeated requests for records if they aren’t built into daily processes.

Screening vs. diagnostic consistency: Ensure diagnosis, intent, and modifiers align for colonoscopies that convert to diagnostic work.
Anorectal testing modernization: Retire deleted codes (91120/91122) and align documentation to the newer bundled descriptors.
Remote monitoring compliance: Confirm automatic transmission requirements for 99454 are met and documented.
Global period awareness: Treat 90-day global rules for 43889 as an operational compliance item, not an afterthought.

If your team misses just one 2026 compliance detail, payers will reject the claim—and you’ll be stuck reworking it.

We routinely see practices lose time and cash flow due to preventable rejections and reprocessing—especially around screening conversions, remote monitoring requirements, and documentation that doesn’t match updated code descriptors.

Guarantee: We’ll identify the exact 2026 risk points in your GI billing workflow and show you how to eliminate them.

Check My 2026 Risk Points

Essential Gastroenterology Modifiers for 2026

Modifier	Description	2026 Application
-33	Preventive Service	Used with screening colonoscopy to indicate zero cost-sharing
-PT	Screening converted to diagnostic	Required by Medicare when biopsy/polypectomy occurs
-25	Separate E/M	For unrelated same-day visits (e.g., IBD flare)
-53	Discontinued Procedure	Use when colonoscopy is incomplete due to prep or safety
-XS	Separate Structure	Preferred over -59 in 2026 for distinct lesions

CMS continues encouraging use of X-modifiers (like -XS) instead of the general -59 to reduce audit risk.

Modifiers are where GI claims go to die—especially preventive and screening conversion rules.

We see payers deny claims when -PT or -33 is missing/misapplied, when -25 is appended without a clearly separable E/M “story,” or when distinct-service logic isn’t defensible. We know which modifier mistakes repeatedly block payment—and how to correct them.

Guarantee: We’ll identify your top modifier-driven denials and tell you exactly what to change to prevent repeat denials.

Analyze My Modifier Denials

Common ICD-10-CM Codes Used in Gastroenterology

ICD-10 Code	Description
Z12.11	Encounter for screening for malignant neoplasm of colon
K50.90	Crohn’s disease, unspecified, without complications
K51.90	Ulcerative colitis, unspecified, without complications
K21.9	Gastro-esophageal reflux disease without esophagitis
K74.60	Unspecified cirrhosis of liver
R10.13	Epigastric pain
K92.1	Melena

A “right CPT®” can still deny if the diagnosis doesn’t support medical necessity.

We see denials when ICD-10 selection doesn’t align with payer policy—especially around screening colonoscopies (Z12.11), IBD care (K50.90/K51.90), cirrhosis management (K74.60), and symptom-driven visits that were scheduled as “screening.” Medical-necessity mismatches are a silent AR killer because they look “coded” but won’t pay.

Guarantee: We’ll identify your most common CPT®/ICD mismatches and provide fixes that reduce medical-necessity denials.

Review My CPT/ICD Denials

2026 Revenue & Compliance Warnings

Facility vs. Office Gap

The 2026 fee schedule significantly increased payment for office-based endoscopy while reducing facility-based reimbursement in ASCs and hospitals. Practices capable of performing small-bore dilations or hemorrhoid bandings in-office may see improved margins.

E/M Add-On Code G2211

Gastroenterologists managing complex, longitudinal conditions such as IBD, Hepatitis C, or cirrhosis can report add-on code G2211 with outpatient E/M visits. This provides incremental revenue for ongoing specialty care.

Screening vs. Diagnostic Scrutiny

Payers are using AI-based claim review systems in 2026 to detect inconsistencies between diagnosis and intent. If a patient presents with symptoms but is scheduled as screening, the claim must reflect diagnostic coding to avoid audit flags.

GI compliance risk usually shows up as denials first—then audits later.

When screening logic, diagnosis support, and documentation structure don’t match payer policy, claims don’t just deny—they can trigger repeated requests for records or retrospective scrutiny. We help teams close those gaps before they become expensive problems.

Guarantee: We’ll identify the compliance-driven denial patterns in your GI claims and give you a clear fix plan.

Reduce My GI Compliance Denials

Contact us to receive a Denial Snapshot that highlights compliance risks and the documentation fixes that protect reimbursement.

2026 Gastroenterology Summary Table

2026 Status	Code(s)	Impact on GI Practice
New Category I	43889	Permanent ESG code with 90-day global period
Modernized	91124–91125	Replaces legacy anorectal physiology codes
Graduated	47384	IRE liver ablation now permanent Category I
Remote Monitoring	99445, 99470	Lower threshold for chronic GI data review
Efficiency Adjustment	45378–45385	-2.5% work RVU reduction

Gastroenterology Billing Tips for 2026

Make screening logic airtight. Align diagnosis, intent, and modifiers for colonoscopy claims that convert to diagnostic.
Retire legacy anorectal testing codes. Update templates and charge capture to 91124–91125 and document medical necessity clearly.
Build remote monitoring compliance into workflow. Confirm 99454 automatic transmission requirements and track time consistently for 99470.
Respect global periods. Ensure routine post-op care for 43889 is not billed separately unless unrelated.
Protect E/M reimbursement. When billing E/M with other services, separate the clinical “story” from the procedure note and apply modifiers appropriately.

If these “simple tips” aren’t built into your workflow, denials keep coming back—month after month.

Most teams know the rules, but denials persist because templates, charge capture, and documentation habits don’t match what payers require for 2026—especially around screening conversions, anorectal testing modernization, and remote monitoring compliance.

Guarantee: We’ll deliver a Denial Snapshot that identifies the exact process gaps causing denials—and a plan to fix them.

Get My Workflow Fix Plan

Contact us to receive a Denial Snapshot that turns your denial patterns into a clear action plan for higher reimbursement.

Final Thoughts

Gastroenterology billing in 2026 centers on modernization. ESG is now permanent. Anorectal physiology testing is streamlined. Remote monitoring is easier to bill but more tightly regulated. At the same time, reimbursement pressure makes clean documentation and correct modifier use essential.

Work with an expert medical billing team

If you’re still chasing GI denials, you’re losing revenue and time you’ll never get back.

Whether your pain is screening conversion rules (-PT, -33), modifier issues, diagnosis support, remote monitoring compliance, or documentation structure, we’ve seen these exact problems across gastroenterology and know how to correct them quickly.

Guarantee: We’ll identify your top denial causes and give you a concrete plan to fix them—so you can get paid.

Get My GI Denial Snapshot

Contact us today to receive your Denial Snapshot and start reducing denials, speeding up payment, and protecting reimbursement.

Trademark notice: CPT is a registered trademark of the American Medical Association.

Neurology CPT® Codes for 2026 + Modifiers

When it comes to neurology medical billing, precision is vital. Incorrect code usage can lead to missed reimbursement, claim rejections, or audit risk—especially when you’re working with time-based services, remote monitoring, and EEG-related reporting. For 2026, neurology practices should review the latest CPT® updates, including expanded remote monitoring options and new Category III codes tied to EEG services.

Neurology denials aren’t “random”—they’re driven by predictable documentation and time-reporting gaps.

We see the same breakdowns repeatedly: remote monitoring minutes not supported, unclear device supply duration, mismatched payer policies for emerging Category III EEG services, and telehealth modifier errors that trigger automatic edits.

Guarantee: We’ll identify your top neurology denial drivers and give you a clear plan to reduce rejections and improve payment speed.

Get My Neurology Denial Snapshot

Neurology 2026 CPT® Code Updates

Remote monitoring continues to expand in 2026. In addition to the familiar Remote Therapeutic Monitoring (RTM) codes used for 16–30 days of monitoring, 2026 adds options that better reflect shorter-duration monitoring and lower time thresholds for treatment management.

That matters because payers are increasingly strict about two things: (1) whether the documented monitoring period matches the code’s required duration, and (2) whether staff/provider time is supported in the clinical record. When either one is missing, claims tend to deny quickly—especially when monitoring is billed month-over-month.

Here are key remote monitoring updates to know for 2026:

98975 – RTM initial setup and patient education on use of equipment
98976 – RTM device supply for monitoring the respiratory system, 16–30 days in a 30-day period
98977 – RTM device supply for monitoring the musculoskeletal system, 16–30 days in a 30-day period
98978 – RTM device supply for monitoring cognitive behavioral therapy (CBT), 16–30 days in a 30-day period
99445 – Remote monitoring device supply and transmission for a shorter monitoring duration (2–15 days in a 30-day period)
98980 – RTM treatment management services, first 20 minutes of clinical staff or physician/QHP time in a calendar month
98981 – RTM treatment management services, each additional 20 minutes in a calendar month
99470 – Remote monitoring treatment management, first 10 minutes (lower threshold than the 20-minute requirement tied to 98980/99457-style reporting)

Remote Monitoring Documentation That Payers Expect

Tip: For remote monitoring claims, document (1) the monitoring window (days), (2) what was monitored and why, (3) the clinical response or care-plan change, and (4) staff/QHP time logs that support any time-based management services.

Remote monitoring reimbursement breaks when your record doesn’t prove time, duration, and clinical action.

We see denials when teams bill supply/transmission without clearly supporting the monitoring duration—or bill time-based management without a defensible time trail and clinical decision-making tied to the data.

Guarantee: We’ll pinpoint the exact documentation gaps causing remote monitoring denials and show you what to fix so the next cycle pays.

Review My Remote Monitoring Claims

New Neurology-Specific Category III Codes for 2026

Neurology also gained new Category III (emerging technology) codes in 2026. These are especially relevant for facilities and providers reporting continuous EEG monitoring and AI-supported EEG waveform analysis.

X461T–X466T – Continuous EEG monitoring services (Category III)
X504T – Augmentative algorithmic (AI-supported) analysis of encephalographic (EEG) waveforms (Category III)

Because Category III codes often have payer-specific coverage rules, denials frequently occur when prior authorization is missing, documentation doesn’t match the descriptor intent, or the payer requires an alternate reporting pathway. That doesn’t mean you shouldn’t bill them—it means you should treat them as “high-attention” services that require tighter front-end checks.

Category III Reality Check

Tip: Before submitting Category III EEG claims, confirm payer coverage rules, authorization requirements, and any documentation checklist expectations. A “covered drug/service” is not the same as a “cleanly payable claim.”

Category III EEG claims can stall fast if payer requirements aren’t handled up front.

We often see delays tied to missing authorization, mismatched documentation, or payer-specific edits that flag emerging technology codes for manual review.

Guarantee: We’ll identify where your Category III EEG workflow is vulnerable and provide a fix plan that reduces delays and rework.

Check My Category III EEG Risk

Neurology CPT® Code Ranges for 2026

The CPT® code ranges below are frequently used for neurology and neuromuscular procedures. Always confirm payer guidance and the most current CPT® descriptors before filing claims.

95700-95811 – Long-term EEG Procedures and Sleep Medicine Testing
95812-95830 – Routine EEG Procedures
95829-95836 – Electrocorticography
95851-95857 – Testing Range of Motion
95860-95872 – Electromyography Procedures
95873-95887 – Guidance Procedures for Chemo Denervation and Ischemic Muscle Testing Procedures
95905-95913 – Nerve Conduction test
95919-95924 – Autonomic Function testing procedure
95925-95937 – Evoked Potentials and Reflex testing procedure
95938-95941 – Intraoperative Neurophysiology procedure
95970-95984 – Neurostimulators Analysis-Programming procedure
95990-95999 – Other Neurology and Neuromuscular procedure
96000-96004 – Motion analysis procedure
96020-96020 – Functional Brain Mapping

These ranges are helpful for quick reference, but claims success still depends on the “supporting story” in the note—medical necessity, accurate test indication, and complete technical/professional documentation where applicable.

The right code range doesn’t guarantee payment—documentation does.

We see denials when test indications are vague, documentation is incomplete for technical vs professional components, or payer policies require additional elements that weren’t captured in the note.

Guarantee: We’ll identify your most common neurology documentation gaps that lead to denials and show you how to fix them.

Review My Neurology Documentation Gaps

Neurology CPT® Modifiers for 2026

CPT® modifiers help make a code more specific. In 2026, Modifier 93 and 95 remain important for telehealth reporting, but it’s also worth noting how Appendix T impacts audio-only reporting for certain services.

93 – Audio-only telemedicine (used when the payer allows real-time audio-only reporting for the service)
95 – Synchronous telemedicine service rendered via real-time interactive audio and video telecommunications

Pro tip for 2026: Many behavioral health and neuropsychological testing codes (including 96130–96133) are recognized in CPT® Appendix T for audio-only reporting with Modifier 93, which can help support compliant telehealth billing when video is not available.

Telehealth Modifier Risk in Neurology

Tip: Payers often reject telehealth claims when place of service, telehealth indicators, and modifiers don’t align. Build a consistent telehealth checklist so your workflow isn’t dependent on memory.

Telehealth claims deny quickly when modifiers and payer rules don’t match.

We see avoidable rejections when Modifier 93 or 95 is used inconsistently, or when payer-specific telehealth requirements aren’t reflected in the claim’s supporting details.

Guarantee: We’ll identify where telehealth coding and modifier usage is creating denials—and provide a correction plan.

Analyze My Telehealth Denials

Summary Table of 2026 Additions

New 2026 Code	Description
99445	Remote monitoring supply/transmission (short duration: 2–15 days)
99470	Remote monitoring treatment management (first 10 minutes)
X461T–X466T	Continuous EEG monitoring services (Category III)
X504T	AI-driven (augmentative algorithmic) analysis of EEG waveforms (Category III)

A Quick 2026 “Watch List” for Neurology Teams

Most neurology revenue-cycle issues in 2026 won’t come from a lack of codes—they’ll come from missed payer expectations. Use this watch list to reduce preventable denials and rework:

Short-duration monitoring support: Make sure documentation supports the monitoring window and the clinical rationale for monitoring.
Time-based management defensibility: Keep a reliable time trail and clearly link monitoring data to clinical decisions or care-plan updates.
Category III coverage friction: Confirm payer-specific requirements (including authorization) for EEG-related emerging technology services.
Telehealth modifier alignment: Don’t assume Modifier 93 or 95 is accepted for every service—verify payer rules and code eligibility.

If your team misses one payer rule, you’ll feel it in denials—and delayed cash flow.

We help neurology practices eliminate preventable breakdowns: documentation gaps, modifier errors, and remote monitoring workflow issues that stop claims from paying.

Guarantee: We’ll identify your highest-risk neurology billing issues for 2026 and provide a clear plan to fix them.

Check My 2026 Neurology Billing Risk

Neurology Billing Tips for 2026

Build a remote monitoring checklist. Include duration support, device documentation, and a consistent approach to time logging.
Defend time-based services. Ensure time is traceable and tied to clinical action, not just “reviewed.”
Treat Category III EEG codes as high-attention claims. Confirm authorization, coverage, and documentation requirements before submission.
Standardize telehealth modifier usage. Align Modifier 93 and 95 with payer rules and ensure claim fields match telehealth requirements.
Reduce rework with templates. Build documentation prompts into note templates so compliance doesn’t depend on memory.

If these steps aren’t built into your workflow, denials will keep coming back.

Most teams know the rules. Denials persist because documentation and billing workflows don’t consistently reflect payer expectations for remote monitoring, telehealth, and emerging EEG services.

Guarantee: We’ll deliver a Denial Snapshot that turns your denial patterns into a clear fix plan.

Get My Neurology Workflow Fix Plan

Final Thoughts

Neurology billing in 2026 is increasingly shaped by remote monitoring, telehealth modifier compliance, and emerging EEG technologies. Keeping your CPT® coding current is important—but building a workflow that consistently supports medical necessity, time reporting, and payer requirements is what protects revenue long-term.

If you’re still chasing neurology denials, you’re losing revenue and time you can’t recover.

Whether your pain is remote monitoring compliance, telehealth modifier usage, Category III EEG billing, or documentation support, we’ve seen these patterns across neurology and know how to correct them quickly.

Guarantee: We’ll identify your top denial causes and give you a concrete plan to fix them—so you can get paid.

Get My Neurology Denial Snapshot

Contact us today to receive your Denial Snapshot and start reducing denials, speeding up payment, and protecting reimbursement.

Trademark notice: CPT is a registered trademark of the American Medical Association.

Audiology CPT® Codes for 2026 + Modifiers

Accurate CPT® coding and modifier use are essential for audiologists to ensure proper reimbursement, reduce denials, and stay compliant with payer documentation rules. In 2026, audiology practices should pay special attention to a major update impacting hearing aid and hearing device-related professional services, along with ongoing best practices for vestibular and audiometric testing.

In audiology, denials are typically driven by predictable issues: outdated code use, time-based services without defensible time documentation, vestibular tests billed in overlapping combinations, and modifier selection that doesn’t match what the note actually supports.

Audiology denials usually come from documentation gaps—not “bad luck.”

We see claims denied for continued use of deleted codes, time-based device services without total time, vestibular test overlap that triggers bundling edits, and modifier use that isn’t clearly supported in the record.

Guarantee: We’ll identify the top denial drivers in your audiology claims and give you a clear fix plan your team can implement immediately.

Get My Audiology Denial Snapshot

Major Audiology CPT® Updates for 2026

Critical update: Effective January 1, 2026, the legacy hearing aid/hearing device service codes 92590–92595 have been deleted and replaced by a new set of 12 CPT® codes (92628–92642) that more specifically describe hearing device professional services, including time-based reporting for certain components of care.

These changes apply to CPT® professional service reporting and do not replace HCPCS “V” codes used for hearing aid devices when applicable. Payer adoption and coverage policies may vary, so it is important to confirm plan requirements when implementing the new code set.

If your templates still include 92590–92595, payers will reject the claim.

Invalid-code rejections are avoidable, but they still disrupt cash flow and create rework. The transition to 92628–92642 is a workflow change, not just a coding change.

Guarantee: We’ll pinpoint where deleted codes or outdated device-service workflows are creating denials and give you a transition plan that sticks.

Check My 2026 Code Transition Risk

Hearing Device Professional Service Codes for 2026 (New)

The following codes describe professional services related to hearing device care. Several of these codes are time-based and require documentation that supports the time and work performed (for example: candidacy evaluation, device selection, fitting, follow-up, and verification).

92628–92632 – Evaluation services and hearing device selection (time-based options included)
92634–92637 – Hearing device fitting and post-fitting follow-up services
92638–92639 – Electroacoustic analysis/verification services
92641–92642 – Additional verification and/or related device service components

Documentation Tip for the New 2026 Hearing Device Codes

Tip: For time-based hearing device services, document what was performed (candidacy, selection, fitting, verification), total time, and any key clinical findings that support medical necessity and the level of service.

Time-based services are especially vulnerable to denial when the note does not clearly support:

What work was performed during the billed time
Total time (and, when applicable, how time was measured)
Clinical reasoning and findings supporting the service

Time-based device services deny when the payer can’t “see the work” in the note.

We see denials when total time is missing, when services are described too generally (“counseled patient”), or when the documentation doesn’t connect the service to clinical findings and next steps.

Guarantee: We’ll identify why your time-based hearing device services are being downcoded or denied and show you exactly what to change.

Review My Time-Based Device Claims

Vestibular Implant Procedures (Category III)

These Category III codes describe emerging vestibular implant technologies and related services. Coverage and payment are payer-dependent.

0725T – Surgical implantation or removal of a vestibular implant.
0726T – Surgical implantation or removal of a vestibular implant, alternative procedural approach.
0727T – Surgical implantation or removal of a vestibular implant using a different technique.
0728T – Initial setup, calibration, and configuration of a vestibular implant for diagnostic analysis, unilateral.
0729T – Subsequent programming, adjustment, and configuration of a vestibular implant for diagnostic analysis, unilateral.

Because Category III reimbursement varies significantly by payer, documentation and authorization workflows are especially important. When claims deny here, it’s often due to coverage limitations—not coding errors—so confirming payer rules up front protects your time and your patient’s expectations.

Vestibular and Balance Testing

Vestibular testing supports evaluation of dizziness, vertigo, imbalance, and suspected vestibular disorders. Many services are comprehensive and can be subject to bundling edits, so the test performed should drive code selection.

92517 – Cervical vestibular evoked myogenic potential (cVEMP) testing, with interpretation and report.
92518 – Ocular vestibular evoked myogenic potential (oVEMP) testing, with interpretation and report.
92519 – Combined cVEMP and oVEMP testing, with interpretation and report.
92537 – Bilateral caloric vestibular testing with bithermal irrigations, with recording.
92538 – Bilateral caloric vestibular testing with monothermal irrigations, with recording.
92540 – Comprehensive vestibular evaluation including multiple nystagmus tests, optokinetic stimulation, and tracking, with recording.
92541 – Spontaneous, gaze, and fixation nystagmus testing, with recording.
92542 – Positional nystagmus testing in multiple positions, with recording.
92544 – Optokinetic nystagmus testing with bidirectional stimulation.
92545 – Oscillating tracking test for eye movements.
92546 – Sinusoidal vertical axis rotational testing.
92547 – Use of vertical electrodes during vestibular testing (reported separately when applicable).
92548 – Computerized dynamic posturography evaluating sensory organization, with interpretation and report.
92549 – Computerized dynamic posturography including sensory organization, motor control, and adaptation testing.

Caloric Testing Note (92543)

Tip: CPT® 92543 (each irrigation) may be used when fewer irrigations are performed and a complete bithermal (92537) or monothermal (92538) study is not reported. Avoid reporting 92543 alongside 92537/92538 for the same caloric testing, as payers often treat these as overlapping methods of reporting.

Denials in vestibular testing often stem from two issues: (1) medical necessity is not clearly documented, or (2) the combination of codes triggers bundling edits. Clear symptom documentation (what the patient is experiencing, severity, duration, and functional impact) strengthens medical necessity and supports comprehensive services.

Vestibular claims deny when payers see “overlap” or weak medical necessity.

We see denials when comprehensive vestibular services are billed without documentation that matches the clinical indication, or when overlapping caloric reporting triggers edits.

Guarantee: We’ll identify your most common vestibular denial patterns and provide a documentation-and-coding fix plan.

Fix My Vestibular Denials

Audiometric Testing

Audiometric testing codes remain among the most common services billed in audiology. Select codes based on what was actually performed (air vs. air/bone thresholds, speech testing, and whether comprehensive testing applies).

92550 – Tympanometry and acoustic reflex threshold testing.
92552 – Pure tone audiometry, air conduction only.
92553 – Pure tone audiometry, air and bone conduction.
92555 – Speech audiometry threshold testing.
92556 – Speech audiometry threshold testing with speech recognition.
92557 – Comprehensive audiometry threshold evaluation and speech recognition.
92561 – Bekesy audiometry.
92562 – Loudness balance testing.
92563 – Tone decay testing.
92564 – Short increment sensitivity index (SISI) testing.

Many payer issues here come down to mismatched documentation: the claim says “comprehensive,” but the note reads like a limited test battery. Making sure the audiogram/testing narrative matches the billed service is a simple way to prevent denials.

Audiology Billing Modifiers

Modifiers may be needed to indicate repeat testing, laterality, or distinct services performed on the same date. Always follow payer policy and ensure documentation supports modifier use.

Modifier	Description
-59	Distinct procedural service when separately identifiable (use carefully and only when supported)
-76	Repeat procedure by the same provider
-77	Repeat procedure by a different provider
-LT / -RT	Left ear / Right ear, when required by payer policy
-52	Reduced services

Modifiers are where audiology claims get delayed—especially -59 and laterality.

We see denials when -59 is appended without a defensible “distinct service” story, or when LT/RT isn’t used the way a payer expects for ear-specific services.

Guarantee: We’ll identify your modifier-driven denials and tell you exactly what to change to prevent repeat denials.

Analyze My Modifier Denials

A Quick 2026 “Watch List” for Audiology Teams

Remove deleted device-service codes. Claims billed with 92590–92595 will fail once payers enforce the deletion.
Time-based device services require defensible time. Document total time and the work performed (selection, fitting, verification, follow-up).
Expect scrutiny on vestibular combinations. Overlap and bundling edits increase when test batteries aren’t clearly documented.
Laterality rules vary by payer. LT/RT and “distinct service” logic must match payer requirements, not just clinical workflow.

If your team misses one 2026 change, payers will reject the claim—and you’ll be stuck reworking it.

These aren’t “hard denials.” They’re preventable breakdowns in templates, charge capture, and documentation habits—especially around the transition to 92628–92642.

Guarantee: We’ll identify your 2026 code-transition risks and show you how to eliminate them before they hit submission.

Check My 2026 Workflow Risk

Audiology Billing Tips for 2026

Update hearing device workflows. Remove deleted codes 92590–92595 from templates and adopt the new 92628–92642 code family where applicable.
Support time-based reporting. For time-based hearing device services, include total time and clearly document what was performed.
Document medical necessity. Vestibular and balance testing should be supported by symptoms such as dizziness, vertigo, imbalance, or suspected vestibular dysfunction.
Avoid unbundling and overlap. Many vestibular services are comprehensive; choose codes that match the test performed and avoid reporting overlapping caloric methods together.
Use modifiers carefully. Apply -59 or laterality modifiers only when documentation clearly supports distinct testing or payer requirements.

If these rules aren’t built into workflow, denials keep coming back—month after month.

Most teams know the basics, but denials persist because templates, charge capture habits, and documentation structure don’t match payer expectations for 2026 device services and vestibular testing.

Guarantee: We’ll deliver a Denial Snapshot that identifies the process gaps causing denials—and a plan to fix them.

Get My Workflow Fix Plan

Final Thoughts

2026 brings a meaningful shift in how hearing device professional services are reported, while diagnostic audiology and vestibular testing codes remain core to day-to-day billing. Keeping your audiology CPT® codes and modifiers for 2026 current—and aligning documentation with payer expectations—helps protect reimbursement, reduce denials, and maintain compliance.

If your audiology claims are delaying payment, you’re losing time and revenue you won’t get back.

Whether the issue is the 92590–92595 deletion, time-based device services under 92628–92642, vestibular bundling edits, or modifier-driven denials, we’ve seen these exact problems and know how to correct them quickly.

Guarantee: We’ll identify your top denial causes and deliver a concrete plan to reduce denials and speed up reimbursement.

Get My Audiology Denial Snapshot

Contact us today to receive your Denial Snapshot and start reducing denials, protecting reimbursement, and improving cash flow.

Trademark notice: CPT is a registered trademark of the American Medical Association.

Infusion CPT® Codes for 2026 + Modifiers

Infusion centers administer a broad range of therapies—from hydration and antibiotics to chemotherapy and high-cost biologics—often during the same patient encounter. That complexity is exactly why precise use of infusion CPT® codes and modifiers for 2026 matters so much. When hierarchy rules, time documentation, drug classification, or wastage reporting are even slightly off, payers don’t partially pay—they deny.

In 2026, enforcement around JW/JZ modifiers, hydration medical necessity, chemotherapy classification, and time-based reporting continues to tighten. If your team is still relying on habit instead of documented sequencing rules, this update will help align your infusion coding and documentation with today’s payer scrutiny.

Infusion denials follow predictable patterns.

We consistently see claims denied for hierarchy missteps, unsupported additional hours, hydration without medical necessity, and JW/JZ reporting errors. These aren’t random—they’re workflow breakdowns.

Guarantee: We’ll identify the top denial drivers in your infusion claims and give you a clear, step-by-step fix plan.

Get My Infusion Denial Snapshot

E/M Services and Same-Day Infusions

Infusion encounters frequently include evaluation and management (E/M) services. However, billing an E/M on the same day as an infusion requires documentation supporting a significant, separately identifiable service beyond routine pre-infusion assessment.

Payers commonly deny E/M services appended with modifier -25 when documentation only reflects vitals review, medication verification, or infusion consent discussion. Those services are typically considered inherent to drug administration.

To withstand review, documentation must clearly demonstrate medical decision-making unrelated to the infusion procedure itself.

Same-day E/M + infusion billing is a high-audit area.

Modifier -25 appended without defensible documentation is one of the most common infusion denial triggers.

Guarantee: We’ll review your E/M + infusion claims and identify bundling risk before auditors do.

Analyze My E/M + Infusion Claims

Initial Infusion Services and Hierarchy Rules

Correct selection of the initial administration code establishes the foundation for reimbursement. CPT® hierarchy rules require chemotherapy/complex drug administration to take precedence over therapeutic infusions, and therapeutic services to take precedence over hydration.

CPT® Code	Description
96365	IV infusion, therapeutic, prophylactic, or diagnostic; initial, up to 1 hour
96360	IV hydration infusion, initial, up to 1 hour
96413	Chemotherapy/complex drug infusion, initial, up to 1 hour
96401	Chemotherapy administration, subcutaneous or intramuscular

Only one initial administration code is typically reported per vascular access site per encounter. Billing multiple initial services without documentation supporting distinct IV access points commonly results in downcoding or denial.

Misclassifying monoclonal antibodies or biologics under therapeutic infusion rather than chemotherapy/complex drug hierarchy can significantly reduce reimbursement and trigger recoupment risk.

Hierarchy mistakes directly impact reimbursement.

Incorrect initial code selection is one of the most expensive infusion errors—and one of the easiest for payers to flag.

Guarantee: We’ll audit your sequencing patterns and identify revenue leakage tied to hierarchy errors.

Review My Initial Service Coding

Additional Hours, Concurrent Infusions, and Time Documentation

Time-based infusion reporting is under increased payer scrutiny. Additional-hour codes are only reimbursable when clear start and stop times are documented and when infusion duration exceeds the midpoint threshold.

CPT® Code	Description
96366	Each additional hour of therapeutic infusion
96361	Each additional hour of hydration infusion
96415	Each additional hour of chemotherapy/complex drug infusion
96368	Concurrent infusion during a primary service

Vague documentation such as “infused over several hours” will not withstand audit review. Concurrent services must involve distinct substances and cannot simply represent overlapping time documentation without clinical distinction.

Payers frequently downcode additional hours when infusion documentation does not clearly meet duration thresholds.

IV Push and Injection Services

IV push services are distinct from infusion services and are frequently audited due to improper sequencing or unsupported reporting.

CPT® Code	Description
96374	Therapeutic or diagnostic IV push, single or initial substance
96375	Each additional sequential IV push of a different substance
96372	Therapeutic injection, intramuscular or subcutaneous

Incorrect reporting of IV push versus infusion administration method is a common recoupment issue during post-payment audits.

IV push misclassification can trigger repayment demands.

Documentation must clearly distinguish administration method and sequencing to support correct coding.

Guarantee: We’ll identify IV push documentation gaps increasing your audit exposure.

Review My IV Push Claims

Drug Supply, J-Codes, and Wastage Reporting

Accurate drug reporting requires correct alignment between HCPCS J-codes and administration CPT® codes. Payers evaluate not only how the drug was administered, but also how units were calculated and whether wastage reporting is compliant.

For Medicare Part B separately payable drugs from single-dose containers, modifier JW must be reported when drug is discarded, and modifier JZ must be reported when no amount is discarded. Failure to report either modifier when required can result in claim rejection.

Improper unit calculation—especially when vial sizes do not match administered dosage—can trigger both denials and overpayment recoupment.

Infusion Billing Modifiers

Modifier	Description
-59	Distinct procedural service
-25	Significant, separately identifiable E/M service
-91	Repeat laboratory or diagnostic test
-JW	Drug amount discarded and not administered
-JZ	No drug discarded
-JG	340B acquired drug

Modifier misuse—especially -25, -59, JW, and JZ—is one of the most common reasons infusion claims are denied before adjudication.

Modifier errors are silent revenue killers.

Incorrect JW/JZ reporting or unsupported modifier -59 usage can cause rejections before payment is even considered.

Guarantee: We’ll uncover modifier-driven denials and provide a correction roadmap.

Analyze My Modifier Denials

Common ICD-10-CM Codes and Medical Necessity Alignment

ICD-10 Code	Description
Z51.11	Encounter for antineoplastic chemotherapy
Z51.12	Encounter for antineoplastic immunotherapy
Z51.81	Encounter for therapeutic drug monitoring
E86.0	Dehydration
J44.1	Chronic obstructive pulmonary disease with acute exacerbation
M05.79	Rheumatoid arthritis with organ involvement
R50.9	Fever, unspecified

A correct CPT® code can still deny if diagnosis coding does not support medical necessity. Hydration without documented dehydration, fluid loss, or clinical indication is frequently rejected.

Payers often apply medical policy edits linking specific drugs to approved diagnoses. Mismatches result in silent denials that appear “coded correctly” but fail payment criteria.

2026 Watch List for Infusion Centers

Stricter JW/JZ enforcement under Medicare Part B.
Heightened hydration medical necessity audits.
Biologic classification disputes affecting hierarchy.
Expanded time-based audit review of infusion duration documentation.
340B reporting scrutiny tied to modifier -JG.

Final Thoughts

Using infusion CPT® codes and modifiers for 2026 accurately protects revenue, reduces denials, and strengthens compliance. When hierarchy rules, drug classification, time documentation, and modifier use are built into workflow—not left to memory—reimbursement becomes predictable instead of reactive.

If infusion denials are slowing your cash flow, we can help.

From hierarchy sequencing to JW/JZ compliance and medical necessity alignment, we’ve seen the patterns that block infusion reimbursement—and how to fix them fast.

Guarantee: We’ll deliver a Denial Snapshot that shows exactly what’s costing you revenue and how to stop it.

Get My Infusion Denial Snapshot

Trademark notice: CPT is a registered trademark of the American Medical Association.

Urology CPT® Codes for 2026 + Modifiers

Urology billing covers everything from routine office visits to diagnostic cystoscopy and high-dollar surgeries—often in the same episode of care. That variety is exactly why consistent documentation, clean coding, and smart modifier use matter so much in 2026. If your team is still working from last year’s favorites list, this update will help you align your most common urology CPT® codes and modifiers for 2026 with today’s coding landscape.

If you want a deeper revenue-cycle view (beyond codes), explore dedicated urology medical billing services.

Denials in urology usually aren’t “random”—they’re caused by predictable coding and documentation gaps.

We see the same issues repeatedly: claims kicked back for same-day E/M + procedures, incomplete documentation supporting medical necessity, and invalid-code rejections when teams keep using last year’s codes. We know where payers push back—and how to fix it fast.

Guarantee: We’ll identify the top denial causes in your urology claims and give you a clear plan to stop them.

Get My Urology Denial Snapshot

Evaluation and Management Codes Common in Urology

Most urology encounters start (and often end) with E/M services. Even when a procedure occurs on the same date, payers expect E/M documentation to clearly stand on its own if it is billed separately.

CPT® Code	Description
99202–99205	New patient office/outpatient visits (levels 2–5)
99212–99215	Established patient office/outpatient visits (levels 2–5)
99221–99223	Initial hospital inpatient or observation care
99231–99233	Subsequent hospital inpatient or observation care

Document the “Why Today”

Tip: When an office visit and a procedure occur on the same date, clearly separate the assessment and plan from the procedure note to support modifier use.

Getting paid for E/M in urology is hard when payers think it’s “bundled” into the procedure.

We see denials when 99213–99215 (or 99202–99205) are billed with common procedures and the documentation doesn’t clearly justify a separate, significant service—especially when modifier -25 is used. We know the wording and structure payers look for, and where documentation typically fails.

Guarantee: We’ll pinpoint exactly why your E/M claims are denied and show you what to change so the next batch pays.

Analyze My E/M + Procedure Denials

Contact us to get a Denial Snapshot highlighting E/M + procedure denial drivers and the fixes that restore reimbursement.

Common Urology Office Procedures and Endoscopy Codes

This table highlights high-frequency office and endoscopic procedures that often drive denials when documentation or modifiers are incomplete.

CPT® Code	Description
51701	Insertion of non-indwelling bladder catheter
51702	Insertion of temporary indwelling catheter (simple)
51703	Insertion of temporary indwelling catheter (complicated)
51798	Post-void residual measurement
52000	Diagnostic cystourethroscopy (cystoscopy)
52204	Cystoscopy with biopsy
52224	Cystoscopy with fulguration or treatment of minor lesion
54150	Circumcision using clamp or device

Critical Update: As of January 1, 2026, CPT® 55700 has been deleted and can no longer be billed. It has been replaced by a more granular family of prostate biopsy codes (55707–55715) that bundle imaging guidance and distinguish between systematic and targeted approaches.

If your cystoscopy claims aren’t paying, it’s usually a documentation/modifier issue—not the code itself.

We routinely see payer edits and denials around 52000, 52204, and 52224 when documentation doesn’t clearly support the indication, distinct services, or when a “distinct procedural service” is implied but not supported. And in 2026, using deleted 55700 will trigger immediate invalid-code rejections. We know the common pitfalls—and how to prevent them before they hit your AR.

Guarantee: We’ll find the exact reasons these claims aren’t paying and provide a fix plan you can implement immediately.

Fix My Cystoscopy Denials

Urology Diagnostic Testing CPT® Codes To Know

Diagnostic testing is a frequent denial trigger in urology, particularly when medical necessity or prior conservative management is not clearly documented.

CPT® Code	Description
81002	Urinalysis, non-automated (without microscopy)
81003	Urinalysis, automated (without microscopy)
51741	Complex uroflowmetry
51784	EMG studies of anal or urethral sphincter
51727	Complex cystometrogram
76856	Pelvic ultrasound, complete
76857	Pelvic ultrasound, limited or follow-up

Diagnostic testing denials happen when payers don’t see medical necessity—so they don’t pay.

For tests like 51741, 51727, 51784, and even imaging like 76856/76857, we commonly see denials tied to missing indications, incomplete symptom documentation, or lack of prior conservative management in the note. We know the patterns payers use to deny these services and what documentation makes claims defensible.

Guarantee: We’ll identify the top medical-necessity denial triggers in your testing claims and show you how to correct them.

Review My Testing Denials

Contact us to receive a Denial Snapshot that pinpoints why your urology diagnostic tests aren’t getting paid—and how to fix it.

Common Surgical Procedures and 2026 New Standards

The 2026 CPT® set includes the transition of Aquablation to a Category I code and a complete restructuring of prostate biopsy reporting.

CPT® Code	Description
52597	New: Aquablation (Category I replacement for 0421T)
55707	New: Prostate biopsy, transrectal ultrasound-guided; systematic
55708	New: Prostate biopsy, transrectal ultrasound-guided; systematic with MRI–ultrasound fusion targeted lesion work
55709	New: Prostate biopsy, transperineal ultrasound-guided; systematic
55715	Add-on: each additional targeted lesion (MRI–US fusion or in-bore CT/MRI guidance)
52356	Cystoscopy with ureteroscopy and laser lithotripsy
50590	Extracorporeal shock wave lithotripsy (ESWL)
52332	Cystoscopy with ureteral stent placement
52601	Transurethral resection of prostate (TURP)
54163	Repair of incomplete circumcision (recircumcision)
55250	Vasectomy

High-dollar urology claims hurt the most when they deny—because every day unpaid is real revenue at risk.

We see denials and payer requests spike when teams don’t fully transition from 0421T → 52597, or when prostate biopsy documentation doesn’t clearly support the new family (55707–55715)—especially systematic vs targeted, transrectal vs transperineal, and how many targeted lesions were performed for 55715. We know exactly what payers ask for and what gets these paid.

Guarantee: We’ll uncover what’s blocking reimbursement on your high-dollar claims and give you a step-by-step fix plan.

Check My High-Dollar Claims

A Quick 2026 “Watch List” for Urology Teams

The deletion of 55700 is the most impactful coding change for 2026. Practices should also ensure they have transitioned from the Category III “T” code (0421T) to the Category I code (52597) for Aquablation. Using deleted codes like 55700 will trigger invalid-code rejections, and failing to adopt the new prostate biopsy code family can increase denials and payer requests for additional documentation.

If your team misses just one 2026 change, payers will reject the claim—and you’ll be stuck reworking it.

We routinely see practices lose time and cash flow due to preventable rejections like billing deleted 55700 or staying on 0421T when 52597 is required. Those aren’t “hard denials”—they’re avoidable workflow breakdowns. We know how to catch them before they hit claims submission.

Guarantee: We’ll identify the exact 2026 code-transition risks in your billing workflow and show you how to eliminate them.

Check My 2026 Code Risk

Urology Billing Modifiers That Prevent Denials

Modifier	When It’s Commonly Used
-25	Separately identifiable E/M on the same day as a procedure
-59	Distinct procedural service (use carefully; payer edits apply)
-76	Repeat procedure by the same provider
-LT / -RT	Laterality for procedures involving paired organs
-52	Reduced services
-50	Bilateral procedure (payer rules vary)
-78	Unplanned return to the operating or procedure room
-79	Unrelated procedure during the post-operative period

Modifiers are where urology claims go to die—especially -25 and -59.

We see payers deny claims when -25 is appended without a clearly separable E/M “story,” or when -59 is used in situations payer edits won’t allow. Laterality (LT/RT) and bilateral rules (-50) can also cause denials when payer-specific rules aren’t followed. We know which modifier mistakes repeatedly block payment—and how to correct them.

Guarantee: We’ll identify your top modifier-driven denials and tell you exactly what to change to prevent repeat denials.

Analyze My Modifier Denials

Common ICD-10-CM Codes Used in Urology

ICD-10 Code	Description
N40.0	Benign prostatic hyperplasia (without LUTS)
N20.0	Calculus of kidney (kidney stone)
R32	Unspecified urinary incontinence
N39.0	Urinary tract infection, site not specified
C61	Malignant neoplasm of prostate
R31.9	Hematuria, unspecified
Z12.5	Encounter for screening for malignant neoplasm of prostate

A “right CPT®” can still deny if the diagnosis doesn’t support medical necessity.

We see denials when ICD-10 selection doesn’t align with payer policy—especially around hematuria (R31.9), stones (N20.0), BPH (N40.0), and screening-related visits (Z12.5). Medical-necessity mismatches are a silent AR killer because they look “coded” but won’t pay. We know how payers evaluate these pairings.

Guarantee: We’ll identify your most common CPT®/ICD mismatches and provide fixes that reduce medical-necessity denials.

Review My CPT/ICD Denials

Urology Billing Tips for 2026

Retire 55700. Ensure clinical and billing templates are updated to the new biopsy code family.
Separate the story. Standalone E/M documentation is essential when billing alongside procedures.
Update Aquablation coding. Use 52597 for 2026 claims instead of 0421T.
Validate biopsy approach. Documentation must clearly support transrectal vs. transperineal technique and targeted lesions.

If these “simple tips” aren’t built into your workflow, denials keep coming back—month after month.

Most teams know the rules, but denials persist because templates, charge capture, and documentation habits don’t match what payers require for 2026—especially around 55707–55715, same-day E/M + procedure billing, and Aquablation (52597). We help practices turn these rules into repeatable processes that get claims paid.

Guarantee: We’ll deliver a Denial Snapshot that identifies the exact process gaps causing denials—and a plan to fix them.

Get My Workflow Fix Plan

Contact us to receive a Denial Snapshot that turns your denial patterns into a clear action plan for higher reimbursement.

Final Thoughts

Keeping your urology CPT® codes and modifiers for 2026 current helps protect reimbursement, reduce denials, and keep your practice audit-ready. Building an annual code review into your workflow ensures billing accuracy as CPT® standards continue to evolve.

If you’re still chasing urology denials, you’re losing revenue and time you’ll never get back.

Whether your pain is same-day E/M + procedures, modifier misuse, diagnosis support, or the new 2026 transitions (55700 deletion, 52597, 55707–55715), we’ve seen these exact problems across urology and know how to correct them quickly.

Guarantee: We’ll identify your top denial causes and give you a concrete plan to fix them—so you can get paid.

Get My Urology Denial Snapshot

Contact us today to receive your Denial Snapshot and start reducing denials, speeding up payment, and protecting reimbursement.

Trademark notice: CPT is a registered trademark of the American Medical Association.

Hire a Medical Billing Service

Most practices don’t wake up one day and casually decide to hire a billing company. The decision usually comes after a pattern becomes hard to ignore: reimbursement is slowing down, denial volume is increasing, patient balances are piling up, or key staff members are overwhelmed (or leaving). In those moments, choosing to hire a medical billing service isn’t about “outsourcing a task.” It’s about protecting revenue, reducing operational risk, and building a repeatable system that supports growth.

Medical Billing for Multi-Site Practices

As healthcare organizations expand beyond a single location, billing complexity increases rapidly. What works for one office often breaks down when multiple sites, providers, and service lines are added. Differences in front-desk workflows, documentation habits, payer mixes, and staffing can lead to inconsistent billing outcomes—and inconsistent revenue.

RCM Services for Medical Practices

Revenue cycle management (RCM) is the financial backbone of every medical practice. From the moment a patient schedules an appointment to the final payment reconciliation, dozens of steps influence whether revenue is collected accurately and on time. When even one part of that process breaks down, practices feel the impact through delayed payments, rising denials, staff frustration, and limited visibility into financial performance.

Medical Billing Pricing & Fees

For many practices, medical billing pricing & fees is the first question asked—and for good reason. Billing costs directly affect margins, staffing plans, and cash flow stability. But pricing alone doesn’t tell you what you’re actually buying. Two vendors can quote similar numbers while delivering very different levels of denial prevention, follow-up consistency, reporting transparency, and compliance support.